share_log

12 Health Care Stocks Moving In Monday's Pre-Market Session

Benzinga ·  Apr 8 08:09

Gainers

  • Longeveron (NASDAQ:LGVN) shares moved upwards by 75.0% to $3.85 during Monday's pre-market session. The market value of their outstanding shares is at $9.6 million.
  • PetVivo Hldgs (NASDAQ:PETV) stock increased by 17.09% to $1.22. The company's market cap stands at $20.4 million.
  • SHL Telemedicine (NASDAQ:SHLT) stock moved upwards by 13.26% to $6.49. The company's market cap stands at $106.3 million.
  • Pluri (NASDAQ:PLUR) stock moved upwards by 12.02% to $6.15. The market value of their outstanding shares is at $32.1 million.
  • Novo Integrated Sciences (NASDAQ:NVOS) shares moved upwards by 11.35% to $0.5. The company's market cap stands at $8.8 million.
  • Ocugen (NASDAQ:OCGN) stock moved upwards by 8.19% to $1.98. The company's market cap stands at $508.0 million. As per the press release, Q4 earnings came out 4 days ago.

Losers

  • BioRestorative Therapies (NASDAQ:BRTX) stock fell 18.8% to $1.08 during Monday's pre-market session. The company's market cap stands at $7.3 million.
  • Supernus Pharmaceuticals (NASDAQ:SUPN) stock fell 16.34% to $28.07. The company's market cap stands at $1.5 billion.
  • Virpax Pharmaceuticals (NASDAQ:VRPX) stock fell 11.32% to $3.45. The market value of their outstanding shares is at $4.0 million.
  • Adial Pharmaceuticals (NASDAQ:ADIL) stock fell 11.21% to $1.03. The market value of their outstanding shares is at $1.7 million.
  • G1 Therapeutics (NASDAQ:GTHX) shares declined by 10.33% to $4.29. The market value of their outstanding shares is at $223.7 million.
  • GlucoTrack (NASDAQ:GCTK) shares decreased by 9.81% to $0.45. The company's market cap stands at $12.0 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment